CDC6_HUMAN - dbPTM
CDC6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDC6_HUMAN
UniProt AC Q99741
Protein Name Cell division control protein 6 homolog
Gene Name CDC6
Organism Homo sapiens (Human).
Sequence Length 560
Subcellular Localization Nucleus . Cytoplasm . The protein is nuclear in G1 and cytoplasmic in S-phase cells (PubMed:9566895).
Protein Description Involved in the initiation of DNA replication. Also participates in checkpoint controls that ensure DNA replication is completed before mitosis is initiated..
Protein Sequence MPQTRSQAQATISFPKRKLSRALNKAKNSSDAKLEPTNVQTVTCSPRVKALPLSPRKRLGDDNLCNTPHLPPCSPPKQGKKENGPPHSHTLKGRRLVFDNQLTIKSPSKRELAKVHQNKILSSVRKSQEITTNSEQRCPLKKESACVRLFKQEGTCYQQAKLVLNTAVPDRLPAREREMDVIRNFLREHICGKKAGSLYLSGAPGTGKTACLSRILQDLKKELKGFKTIMLNCMSLRTAQAVFPAIAQEICQEEVSRPAGKDMMRKLEKHMTAEKGPMIVLVLDEMDQLDSKGQDVLYTLFEWPWLSNSHLVLIGIANTLDLTDRILPRLQAREKCKPQLLNFPPYTRNQIVTILQDRLNQVSRDQVLDNAAVQFCARKVSAVSGDVRKALDVCRRAIEIVESDVKSQTILKPLSECKSPSEPLIPKRVGLIHISQVISEVDGNRMTLSQEGAQDSFPLQQKILVCSLMLLIRQLKIKEVTLGKLYEAYSKVCRKQQVAAVDQSECLSLSGLLEARGILGLKRNKETRLTKVFFKIEEKEIEHALKDKALIGNILATGLP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
20PhosphorylationSFPKRKLSRALNKAK
HCCHHHHHHHHHHHC
20.6721406692
25UbiquitinationKLSRALNKAKNSSDA
HHHHHHHHHCCCCCC
62.6821906983
27UbiquitinationSRALNKAKNSSDAKL
HHHHHHHCCCCCCCC
60.0021906983
33UbiquitinationAKNSSDAKLEPTNVQ
HCCCCCCCCCCCCCE
59.37-
37PhosphorylationSDAKLEPTNVQTVTC
CCCCCCCCCCEEEEC
38.3523927012
41PhosphorylationLEPTNVQTVTCSPRV
CCCCCCEEEECCCCC
17.3129255136
43PhosphorylationPTNVQTVTCSPRVKA
CCCCEEEECCCCCEE
15.6223401153
45PhosphorylationNVQTVTCSPRVKALP
CCEEEECCCCCEECC
13.3329255136
49UbiquitinationVTCSPRVKALPLSPR
EECCCCCEECCCCCC
45.55-
54PhosphorylationRVKALPLSPRKRLGD
CCEECCCCCCCCCCC
22.259889196
67PhosphorylationGDDNLCNTPHLPPCS
CCCCCCCCCCCCCCC
15.8725159151
74PhosphorylationTPHLPPCSPPKQGKK
CCCCCCCCCCCCCCC
50.439889196
88PhosphorylationKENGPPHSHTLKGRR
CCCCCCCCCCCCCCE
24.7625159151
90PhosphorylationNGPPHSHTLKGRRLV
CCCCCCCCCCCCEEE
32.9320860994
92AcetylationPPHSHTLKGRRLVFD
CCCCCCCCCCEEEEC
52.0719343071
92UbiquitinationPPHSHTLKGRRLVFD
CCCCCCCCCCEEEEC
52.07-
103PhosphorylationLVFDNQLTIKSPSKR
EEECCCEEECCCCHH
19.3224732914
105AcetylationFDNQLTIKSPSKREL
ECCCEEECCCCHHHH
51.5919343071
106PhosphorylationDNQLTIKSPSKRELA
CCCEEECCCCHHHHH
30.479889196
108PhosphorylationQLTIKSPSKRELAKV
CEEECCCCHHHHHHH
51.9724732914
109AcetylationLTIKSPSKRELAKVH
EEECCCCHHHHHHHH
53.9619343071
114UbiquitinationPSKRELAKVHQNKIL
CCHHHHHHHHHHHHH
53.53-
119UbiquitinationLAKVHQNKILSSVRK
HHHHHHHHHHHHHHH
38.15-
122PhosphorylationVHQNKILSSVRKSQE
HHHHHHHHHHHHHHC
30.2024732914
123PhosphorylationHQNKILSSVRKSQEI
HHHHHHHHHHHHHCC
23.6124732914
126UbiquitinationKILSSVRKSQEITTN
HHHHHHHHHHCCCCC
55.10-
127PhosphorylationILSSVRKSQEITTNS
HHHHHHHHHCCCCCC
23.6025159151
131PhosphorylationVRKSQEITTNSEQRC
HHHHHCCCCCCCCCC
21.1224732914
132PhosphorylationRKSQEITTNSEQRCP
HHHHCCCCCCCCCCC
42.2724732914
134PhosphorylationSQEITTNSEQRCPLK
HHCCCCCCCCCCCCC
32.7721815630
151AcetylationSACVRLFKQEGTCYQ
HHHHHHHHCCCCHHH
52.6226051181
151SumoylationSACVRLFKQEGTCYQ
HHHHHHHHCCCCHHH
52.62-
151SumoylationSACVRLFKQEGTCYQ
HHHHHHHHCCCCHHH
52.62-
151UbiquitinationSACVRLFKQEGTCYQ
HHHHHHHHCCCCHHH
52.62-
166PhosphorylationQAKLVLNTAVPDRLP
HHHHHHCCCCCCCCC
25.5229632367
194UbiquitinationREHICGKKAGSLYLS
HHHHCCCCCCCEEEC
43.17-
199PhosphorylationGKKAGSLYLSGAPGT
CCCCCCEEECCCCCC
10.6629496907
208UbiquitinationSGAPGTGKTACLSRI
CCCCCCCHHHHHHHH
32.55-
220UbiquitinationSRILQDLKKELKGFK
HHHHHHHHHHHCCCC
53.11-
221UbiquitinationRILQDLKKELKGFKT
HHHHHHHHHHCCCCH
75.48-
235PhosphorylationTIMLNCMSLRTAQAV
HHHHHHCCHHHHHHH
19.5229083192
261UbiquitinationEVSRPAGKDMMRKLE
HCCCHHHHHHHHHHH
44.55-
379UbiquitinationAVQFCARKVSAVSGD
HHHHHHHHHHHCCCH
23.24-
381PhosphorylationQFCARKVSAVSGDVR
HHHHHHHHHCCCHHH
26.4520068231
384PhosphorylationARKVSAVSGDVRKAL
HHHHHHCCCHHHHHH
29.0620068231
389UbiquitinationAVSGDVRKALDVCRR
HCCCHHHHHHHHHHH
53.82-
406UbiquitinationEIVESDVKSQTILKP
HHHHCCCCCCCCCCC
41.66-
407PhosphorylationIVESDVKSQTILKPL
HHHCCCCCCCCCCCH
32.1924732914
409PhosphorylationESDVKSQTILKPLSE
HCCCCCCCCCCCHHH
35.0529214152
412UbiquitinationVKSQTILKPLSECKS
CCCCCCCCCHHHCCC
39.81-
415PhosphorylationQTILKPLSECKSPSE
CCCCCCHHHCCCCCC
49.8524732914
418UbiquitinationLKPLSECKSPSEPLI
CCCHHHCCCCCCCCC
62.44-
419PhosphorylationKPLSECKSPSEPLIP
CCHHHCCCCCCCCCC
45.3725159151
421PhosphorylationLSECKSPSEPLIPKR
HHHCCCCCCCCCCCC
59.9621815630
427UbiquitinationPSEPLIPKRVGLIHI
CCCCCCCCCEEEEEH
53.36-
478UbiquitinationLIRQLKIKEVTLGKL
HHHHHCCCCCHHHHH
44.54-
481PhosphorylationQLKIKEVTLGKLYEA
HHCCCCCHHHHHHHH
30.77-
484UbiquitinationIKEVTLGKLYEAYSK
CCCCHHHHHHHHHHH
51.51-
491UbiquitinationKLYEAYSKVCRKQQV
HHHHHHHHHHHHHHC
32.45-
495UbiquitinationAYSKVCRKQQVAAVD
HHHHHHHHHHCEEEC
39.70-
527PhosphorylationGLKRNKETRLTKVFF
CCCCCCCCCCEEEEE
32.3722210691
531UbiquitinationNKETRLTKVFFKIEE
CCCCCCEEEEEEECH
41.45-
535UbiquitinationRLTKVFFKIEEKEIE
CCEEEEEEECHHHHH
37.43-
539UbiquitinationVFFKIEEKEIEHALK
EEEEECHHHHHHHHH
51.72-
546UbiquitinationKEIEHALKDKALIGN
HHHHHHHHCHHHHHH
58.95-
548UbiquitinationIEHALKDKALIGNIL
HHHHHHCHHHHHHHH
43.43-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
37TPhosphorylationKinasePLK1P53350
PSP
54SPhosphorylationKinaseCDK2P24941
PSP
74SPhosphorylationKinaseCDK2P24941
PSP
106SPhosphorylationKinaseCDK2P24941
PSP
-KUbiquitinationE3 ubiquitin ligaseFZR1Q9UM11
PMID:10995389
-KUbiquitinationE3 ubiquitin ligaseCCNFP41002
PMID:26818844
-KUbiquitinationE3 ubiquitin ligaseHUWE1Q7Z6Z7
PMID:18617514
-KUbiquitinationE3 ubiquitin ligaseTOM1O60784
PMID:23129771
-KUbiquitinationE3 ubiquitin ligaseDTLQ9NZJ0
PMID:24434580

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CDC6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDC6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
P2R3B_HUMANPPP2R3Bphysical
10629059
ORC2_HUMANORC2physical
12614612
ORC1_HUMANORC1physical
12614612
MCM7_HUMANMCM7physical
12614612
KPSH1_HUMANPSKH1physical
9889196
CCNA2_HUMANCCNA2physical
9889196
MYC_HUMANMYCphysical
10899308
ORC1_HUMANORC1physical
9566895
CDK2_HUMANCDK2physical
9566895
CCNA2_HUMANCCNA2physical
9566895
MCM3_HUMANMCM3physical
10464337
MCM7_HUMANMCM7physical
10464337
MCM3_HUMANMCM3physical
11046155
ORC2_HUMANORC2physical
11046155
P2R3A_HUMANPPP2R3Aphysical
18397887
MCM8_HUMANMCM8physical
15684404
HUWE1_HUMANHUWE1physical
17567951
ATR_HUMANATRphysical
20048340
ATM_HUMANATMphysical
20048340
ATRIP_HUMANATRIPphysical
20048340
ATR_XENLAatrphysical
20048340
BMI1_HUMANBMI1physical
19462008
CCL2_HUMANCCL2physical
21383955
FZR1_HUMANFZR1physical
14701726
CDC20_HUMANCDC20physical
14701726
ORC1_HUMANORC1physical
15232106
ORC2_HUMANORC2physical
15232106
MCM10_HUMANMCM10physical
15232106
MCM2_HUMANMCM2physical
15232106
ORC3_HUMANORC3physical
15232106
CDN2A_HUMANCDKN2Aphysical
15232106
ARF_HUMANCDKN2Aphysical
15232106
CDN1A_HUMANCDKN1Aphysical
15232106
MCM3_HUMANMCM3physical
15232106
UBE2K_HUMANUBE2Kphysical
21988832
DPOLA_HUMANPOLA1physical
26344197
CDN1A_HUMANCDKN1Aphysical
25241761
CCNF_HUMANCCNFphysical
26818844
GRWD1_HUMANGRWD1physical
25990725

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
613805Meier-Gorlin syndrome 5 (MGORS5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDC6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-54, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-166, AND MASSSPECTROMETRY.

TOP